Vascularized Composite Allotransplantation

This is a major surgery where doctors take multiple tissues, like muscle, bone, and skin, from a donor and connect them to the patient's body. The goal is to rebuild a part of the body that was lost or damaged. The key is that the new tissues get their own blood supply, so they can survive and work properly. It's a complex and risky operation.

Procedure

What people who've had Vascularized Composite Allotransplantation report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Vascularized Composite Allotransplantation

Who It's For

Vascularized composite allotransplantation (VCA) is the transplant of a body part made of several kinds of tissue, such as skin, muscle, bone, nerves and blood vessels, from a donor to a recipient. The part is connected to the recipient's own blood vessels so it survives, and its nerves are joined so that, over time, it can feel and move. The best-known examples are hand and arm transplants and face transplants. Uterus, abdominal wall, penis and larynx (voice box) transplants are also forms of VCA, though far fewer have been done. VCA is considered for people with severe tissue loss from injury, burns, disease or a condition present from birth, when standard reconstructive surgery cannot give acceptable function or appearance. Someone who has lost both hands, or whose facial injuries make eating, speaking or breathing difficult, may be a candidate. Unlike a heart or liver transplant, VCA is not life-saving, yet the recipient must take medicines that suppress the immune system for as long as they keep the transplant, which for most people means for life. A uterus transplant is the exception: it is removed after childbearing and the medicines then stop. That trade-off is the central decision. Prostheses and conventional reconstructive surgery remain the main alternatives, and many people referred for a hand transplant are advised that these suit them better. VCA is performed only at a small number of specialized transplant centers.

Before the Procedure

Evaluation is long and deliberate, often stretching over many months. A team of surgeons, transplant specialists and mental health professionals reviews overall health, existing medical problems and the area to be reconstructed. Blood tests look for antibodies against other people's tissue, which can form after blood transfusions, pregnancy or an earlier transplant. High antibody levels, common after severe burns, make a compatible donor harder to find and can mean a long wait. Psychological and social assessment carries as much weight as the physical workup. The team explores what the person hopes the transplant will do, how they cope with setbacks, who will support them, and whether they understand the risks well enough to give informed consent. Recipients need help at home during a long recovery, a way to reach the transplant center often, and a plan for the ongoing cost of medicines, therapy and follow-up. Once a person is listed, a donor is matched for blood type and tissue type and, for a visible transplant, for size and appearance. The call can come at any time, and the recipient travels to the center for surgery.

During the Procedure

VCA is performed under general anesthesia, so the recipient is asleep throughout. The surgeons fix the donor bone to the recipient's bone, connect arteries and veins so blood flows into the transplant, and repair muscles, tendons, nerves and skin. Restoring blood flow promptly matters, because muscle tolerates time without circulation poorly. These are among the longest operations in surgery. In one published series, each hand transplant took about 18 hours. Anti-rejection treatment begins around the time of surgery, usually with a strong induction medicine given through an IV (a thin tube in a vein) that lowers the number of immune cells that drive rejection.

Recovery & Aftercare

Recovery begins with a hospital stay and continues with months of close follow-up at or near the transplant center. Anti-rejection medicine is taken every day, usually as three drugs: tacrolimus, mycophenolate mofetil and a corticosteroid such as prednisone. Regular blood tests check drug levels and kidney function, and preventive antibiotics and antiviral medicines are given for several months because infection risk is highest early on. Function returns slowly because nerves must regrow from the recipient into the transplant. After a hand transplant, movement for gripping and pinching typically begins three to six months after surgery, and finer control of the small hand muscles comes later, allowing tasks such as eating, shaving and writing. Nearly all hand recipients regain protective sensation (the ability to feel pain, heat and pressure), and most regain finer touch. Intensive therapy and retraining make this possible, and the work can be physically and emotionally draining. Face transplant recipients work on speech, eating and facial movement, and most need at least one revision surgery in the first few years. Rejection is common, especially in the first six months, and it usually shows in the transplanted skin as a new rash, redness or swelling, or as sores and redness inside the mouth after a face transplant. Report these signs to the transplant team promptly: a biopsy often confirms rejection, and an acute episode can usually be treated by adjusting medicines. Missing or stopping anti-rejection medicines is the surest way to lose the transplant, and some recipients have lost theirs this way.

Risks & Complications

The operation itself carries the risks of any very long surgery, along with problems specific to VCA, such as slow bone healing and wound breakdown. In very large transplants, such as an arm attached at the shoulder, the return of blood flow can strain the body enough to be life-threatening. Some transplants fail and have to be removed: in a review of 96 hand transplant recipients, 16 had a transplanted hand removed. For face transplants, about 85% were still functioning, with the recipient alive, five years after surgery and 74% at ten years. Most long-term risk comes from the anti-rejection medicines. Suppressing the immune system raises the risk of infections, including serious fungal and viral infections. Tacrolimus can damage the kidneys: in one study of 70 VCA recipients followed for about eight years, roughly 1 in 10 developed chronic kidney disease and about 1 in 20 reached kidney failure, and some recipients have needed a kidney transplant. High blood sugar or diabetes, high blood pressure and weight gain are also common. Cancer risk rises, especially for skin cancers and for lymph gland cancers (lymphomas) linked to viruses, which makes regular skin checks part of follow-up. Repeated rejection episodes can lead to chronic rejection, which slowly damages the transplant and may end its function. There are personal costs as well: living with a part of another person's body, months of therapy, frequent travel to a distant center and the lifelong cost of care are demanding, and outcomes depend heavily on support and steady medicine-taking. Because few people have had each type of VCA, long-term results are still being learned.

Questions to Ask Your Doctor

  1. 1.Would a prosthesis or conventional reconstructive surgery meet my goals, and how would my function likely compare after each option?
  2. 2.What results have your center's recipients had, including rejection episodes, transplant losses and kidney problems?
  3. 3.Which anti-rejection medicines would I take, and what monitoring would they need for the rest of my life?
  4. 4.How long would rehabilitation last, how often would I need to be at the center, and what help at home would I need?
  5. 5.What would happen if the transplant failed or had to be removed?

Last reviewed • Oct 2026

Educational content, not medical advice.